Imaging features of extramedullary, relapsed, and refractory multiple myeloma involving the liver across treatment with cyclophosphamide, lenalidomide, bortezomib, and dexamethasone.
作者信息
Saboo Sachin S, Fennessy Fiona, Benajiba Lina, Laubach Jacob, Anderson Kenneth C, Richardson Paul G
机构信息
Dana-Farber Cancer Institute, Boston, MA, USA.
出版信息
J Clin Oncol. 2012 Jul 10;30(20):e175-9. doi: 10.1200/JCO.2011.41.1413. Epub 2012 Jun 11.
Abstract
摘要
相似文献
1
Imaging features of extramedullary, relapsed, and refractory multiple myeloma involving the liver across treatment with cyclophosphamide, lenalidomide, bortezomib, and dexamethasone.环磷酰胺、来那度胺、硼替佐米及地塞米松治疗过程中累及肝脏的髓外、复发及难治性多发性骨髓瘤的影像特征
J Clin Oncol. 2012 Jul 10;30(20):e175-9. doi: 10.1200/JCO.2011.41.1413. Epub 2012 Jun 11.
2
Multicenter, phase I, dose-escalation trial of lenalidomide plus bortezomib for relapsed and relapsed/refractory multiple myeloma.来那度胺联合硼替佐米用于复发及复发/难治性多发性骨髓瘤的多中心、I期、剂量递增试验
J Clin Oncol. 2009 Dec 1;27(34):5713-9. doi: 10.1200/JCO.2009.22.2679. Epub 2009 Sep 28.
3
"IM iD"eally treating multiple myeloma.“IM iD”真的能治疗多发性骨髓瘤。
Blood. 2013 Mar 14;121(11):1926-8. doi: 10.1182/blood-2013-01-476267.
4
Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium.来那度胺用于复发难治性骨髓瘤患者：既往对硼替佐米和沙利度胺的反应对治疗疗效的影响。比利时一项医疗需求项目的结果
Acta Clin Belg. 2011 Sep-Oct;66(5):371-5. doi: 10.2143/ACB.66.5.2062589.
5
Treatment of relapsed and refractory myeloma.复发性和难治性骨髓瘤的治疗。
Curr Hematol Malig Rep. 2009 Apr;4(2):99-107. doi: 10.1007/s11899-009-0014-5.
6
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma.来那度胺/地塞米松与环磷酰胺/来那度胺/地塞米松与环磷酰胺/硼替佐米/地塞米松在初诊多发性骨髓瘤中的比较。
Br J Haematol. 2012 Feb;156(3):326-33. doi: 10.1111/j.1365-2141.2011.08949.x. Epub 2011 Nov 23.
7
[Treatment of multiple myeloma with lenalidomide and bortezomib combination therapy].来那度胺与硼替佐米联合疗法治疗多发性骨髓瘤
Nihon Rinsho. 2015 Jan;73(1):130-6.
8
Activity and toxicity profiles of the combinations bendamustine-lenalidomide-dexamethasone and bendamustine-bortezomib-dexamethasone for advanced stage multiple myeloma.苯达莫司汀-来那度胺-地塞米松及苯达莫司汀-硼替佐米-地塞米松联合方案用于晚期多发性骨髓瘤的活性及毒性特征
Leuk Lymphoma. 2014 May;55(5):1191-3. doi: 10.3109/10428194.2013.820289. Epub 2013 Aug 13.
9
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma.来那度胺、硼替佐米和地塞米松治疗复发和复发/难治性骨髓瘤患者的 2 期临床试验。
Blood. 2014 Mar 6;123(10):1461-9. doi: 10.1182/blood-2013-07-517276. Epub 2014 Jan 15.
10
Combination of bortezomib, thalidomide, and dexamethasone in the treatment of relapsed, refractory IgD multiple myeloma.硼替佐米、沙利度胺和地塞米松联合治疗复发难治性IgD型多发性骨髓瘤
Leuk Lymphoma. 2005 Apr;46(4):567-9. doi: 10.1080/10428190400029700.
引用本文的文献
1
Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma.多发性骨髓瘤初始表现为多个类似转移性疾病的肝脏结节。
Case Rep Hematol. 2018 May 24;2018:7954816. doi: 10.1155/2018/7954816. eCollection 2018.
2
Autologous stem cell transplantation in EBV-positive post-renal transplant refractory multiple myeloma: A case report and literature review.EBV 阳性肾移植后难治性多发性骨髓瘤的自体干细胞移植：一例报告及文献综述
Oncol Lett. 2018 May;15(5):7207-7214. doi: 10.3892/ol.2018.8237. Epub 2018 Mar 12.
3
Successful treatment with lenalidomide of secondary multiple myeloma with extramedullary liver plasmacytoma in a renal transplant recipient: A case report and review of the literature.来那度胺成功治疗肾移植受者合并肝髓外浆细胞瘤的继发性多发性骨髓瘤：一例报告并文献复习
Oncol Lett. 2015 Nov;10(5):2931-2936. doi: 10.3892/ol.2015.3729. Epub 2015 Sep 18.
4
Detection of Extramedullary Multiple Myeloma in Liver by FDG-PET/CT.通过氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描（FDG-PET/CT）检测肝脏髓外多发性骨髓瘤
Nucl Med Mol Imaging. 2014 Jun;48(2):166-8. doi: 10.1007/s13139-013-0256-y. Epub 2013 Dec 24.
本文引用的文献
1
Advances in imaging and the management of myeloma bone disease.多发性骨髓瘤骨病的影像学进展与治疗进展。
J Clin Oncol. 2011 May 10;29(14):1907-15. doi: 10.1200/JCO.2010.32.5449. Epub 2011 Apr 11.
2
Non-secretory multiple myeloma relapsing as extramedullary liver plasmacytomas.非分泌型多发性骨髓瘤复发为骨髓外肝浆细胞瘤。
J Gastrointestin Liver Dis. 2011 Mar;20(1):81-3.
3
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma.新型疗法时代多发性骨髓瘤患者发生髓外疾病的情况，以及泊马度胺对髓外骨髓瘤的作用。
Leukemia. 2011 Jun;25(6):906-8. doi: 10.1038/leu.2011.29. Epub 2011 Feb 25.
4
Three cases of bortezomib-resistant multiple myeloma with extramedullary masses.3例伴有髓外肿块的硼替佐米耐药性多发性骨髓瘤
Tokai J Exp Clin Med. 2010 Apr 20;35(1):17-20.
5
Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management.多发性骨髓瘤：2011 年诊断、风险分层和治疗进展。
Am J Hematol. 2011 Jan;86(1):57-65. doi: 10.1002/ajh.21913.
6
Imaging of extraosseous myeloma: CT, PET/CT, and MRI features.骨外骨髓瘤的影像学表现：CT、PET/CT 和 MRI 特征。
AJR Am J Roentgenol. 2010 Nov;195(5):1057-65. doi: 10.2214/AJR.10.4384.
7
Multicenter, phase I, dose-escalation trial of lenalidomide plus bortezomib for relapsed and relapsed/refractory multiple myeloma.来那度胺联合硼替佐米用于复发及复发/难治性多发性骨髓瘤的多中心、I期、剂量递增试验
J Clin Oncol. 2009 Dec 1;27(34):5713-9. doi: 10.1200/JCO.2009.22.2679. Epub 2009 Sep 28.
8
Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients.多发性骨髓瘤髓外疾病的发病情况、表现特征和转归：对 1003 例连续患者的纵向研究。
Ann Oncol. 2010 Feb;21(2):325-330. doi: 10.1093/annonc/mdp329. Epub 2009 Jul 24.
9
Multiple myeloma presenting with [18F]fluorodeoxyglucose avid liver lesions diagnosed on positron emission tomography scan.在正电子发射断层扫描中诊断出的以[18F]氟脱氧葡萄糖摄取性肝脏病变为表现的多发性骨髓瘤。
J Clin Oncol. 2007 Nov 20;25(33):5319-20. doi: 10.1200/JCO.2007.13.4767.
10
New drugs for myeloma.用于治疗骨髓瘤的新药。
Oncologist. 2007 Jun;12(6):664-89. doi: 10.1634/theoncologist.12-6-664.
Zotero 插件